Surgical Case Reports (Mar 2024)

Gastric inflammatory myofibroblastic tumor: a case report

  • Taku Hattori,
  • Yutaka Tanizawa,
  • Tadakazu Shimoda,
  • Yusuke Koseki,
  • Kenichiro Furukawa,
  • Keiichi Fujiya,
  • Daisuke Aizawa,
  • Takashi Sugino,
  • Masanori Terashima,
  • Etsuro Bando

DOI
https://doi.org/10.1186/s40792-024-01844-7
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Inflammatory myofibroblastic tumor (IMT) of the stomach is an uncommon mesenchymal neoplasm. We present a case of gastric submucosal tumor (SMT) where the final diagnosis was IMT. Case presentation A 69-year-old man presented with a 24-mm SMT on the posterior wall of the middle third of the stomach that was detected by screening upper gastrointestinal endoscopy. Abdominal contrast-enhanced computed tomography showed that the tumor was well-enhanced. Although endoscopic ultrasonography-guided biopsy was performed, the histological diagnosis was not confirmed preoperatively. Since the tumor was clinically suspected to be a gastrointestinal stromal tumor, we performed gastric wedge resection by laparoscopic–endoscopic cooperative surgery. Pathologically, proliferative spindle cells with a positive reaction for smooth muscle actin, negativity for c-kit, desmin, s-100, CD34, STAT-6, β-catenin and anaplastic lymphoma kinase 1 were identified. Hence, the tumor was finally diagnosed as an IMT originating from the stomach. Conclusions When an SMT of the stomach is identified, the possibility of gastric IMT should be considered.

Keywords